BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Liver cancer AND PSA AND Diagnosis
82 results:

  • 1. Incidental Detection of Synchronous Benign Hepatic and Splenic Hemangiomas on 18 F-PSMA PET/CT.
    Alsaleh MH; Alkhars AS; Albensaad M; Alsharif A
    Clin Nucl Med; 2024 Jun; 49(6):e298-e300. PubMed ID: 38537220
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Early-stage hepatocellular carcinoma screening in patients with chronic hepatitis B in China: a cost-effectiveness analysis.
    Nan Y; Garay OU; Lu X; Zhang Y; Xie L; Niu Z; Chen W
    J Comp Eff Res; 2024 Apr; 13(4):e230146. PubMed ID: 38415341
    [No Abstract]    [Full Text] [Related]  

  • 3. Aggressive prostatic adenocarcinoma with urothelial-like morphology, with frequent CK7/CK20/HMWK expression and occasional diffuse neuroendocrine features: A clinicopathologic study of 12 cases.
    Nguyen NJ; Sherman C; van der Kwast TH; Downes MR
    Pathol Res Pract; 2024 Feb; 254():155105. PubMed ID: 38218041
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Aberrant expression of GATA3 in metastatic adenocarcinoma of the prostate: an important pitfall.
    Lobo J; Tenace NP; Cañete-Portillo S; Carneiro I; Henrique R; Lucianò R; Harik LR; Magi-Galluzzi C
    Histopathology; 2024 Feb; 84(3):507-514. PubMed ID: 37965687
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. liver Fibrosis Scores and Prostate cancer Risk and Mortality in the Atherosclerosis Risk in Communities Study.
    Wang A; Lazo M; Lu J; Couper DJ; Prizment AE; Vitolins MZ; Denmeade SR; Joshu CE; Platz EA
    Cancer Prev Res (Phila); 2023 Sep; 16(9):523-530. PubMed ID: 37339266
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Mismatched Lesions on 18F-FDG PET and 18F-Fluciclovine PET Images in a Patient With Metastatic Prostate Small Cell Carcinoma.
    Gu J; Lu Y; Xu G
    Clin Nucl Med; 2022 Mar; 47(3):255-257. PubMed ID: 34392287
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. SPECT-CT Imaging with [99mTc]PSMA-T4 in patients with Recurrent Prostate cancer.
    Sergieva S; Mangaldgiev R; Dimcheva M; Nedev K; Zahariev Z; Robev B
    Nucl Med Rev Cent East Eur; 2021; 24(2):70-81. PubMed ID: 34382671
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. [A Case of de novo Neuroendocrine Prostate cancer].
    Kise H; Shiraishi T
    Hinyokika Kiyo; 2021 Mar; 67(3):113-118. PubMed ID: 33957032
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Clinicopathologic features of metastatic small cell carcinoma of the prostate to the liver: a series of four cases.
    Bell PD; Huber AR; Agostini-Vulaj D
    Diagn Pathol; 2021 Apr; 16(1):35. PubMed ID: 33892760
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Over-diagnosed prostate cancer in solid organ recipients: lessons from the last 3 decades.
    Waeckel T; Ait Said K; Altieri M; Belin A; Doerfler A; Tillou X
    Int Urol Nephrol; 2021 Feb; 53(2):241-248. PubMed ID: 32926314
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Current Imaging Techniques for and Imaging Spectrum of Prostate cancer Recurrence and Metastasis: A Pictorial Review.
    Tanaka T; Yang M; Froemming AT; Bryce AH; Inai R; Kanazawa S; Kawashima A
    Radiographics; 2020; 40(3):709-726. PubMed ID: 32196428
    [TBL] [Abstract] [Full Text] [Related]  

  • 12.
    Liu C; Liu T; Zhang Z; Zhang N; Du P; Yang Y; Liu Y; Yu W; Li N; Gorin MA; Rowe SP; Zhu H; Yan K; Yang Z
    J Nucl Med; 2020 Sep; 61(9):1314-1319. PubMed ID: 32034111
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Clinical features of neuroendocrine prostate cancer.
    Conteduca V; Oromendia C; Eng KW; Bareja R; Sigouros M; Molina A; Faltas BM; Sboner A; Mosquera JM; Elemento O; Nanus DM; Tagawa ST; Ballman KV; Beltran H
    Eur J Cancer; 2019 Nov; 121():7-18. PubMed ID: 31525487
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Low-serum prostate-specific antigen level predicts poor outcomes in patients with primary neuroendocrine prostate cancer.
    Wang J; Xu W; Mierxiati A; Huang Y; Wei Y; Lin G; Dai B; Freedland SJ; Qin X; Zhu Y; Ye DW
    Prostate; 2019 Sep; 79(13):1563-1571. PubMed ID: 31376193
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. A primary splenic angiosarcoma hepatic metastasis after splenectomy and its genomic alteration profile.
    Cao L; Hong J; Wang Y; Yu J; Ma R; Li J; Wu J; Zheng S
    Medicine (Baltimore); 2019 Jul; 98(28):e16245. PubMed ID: 31305404
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Association between liver Fibrosis and Serum psa among U.S. Men: National Health and Nutrition Examination Survey (NHANES), 2001-2010.
    Wang A; Lazo M; Carter HB; Groopman JD; Nelson WG; Platz EA
    Cancer Epidemiol Biomarkers Prev; 2019 Aug; 28(8):1331-1338. PubMed ID: 31160348
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Hormone signaling via androgen receptor affects breast cancer and prostate cancer in a male patient: A case report.
    Takuwa H; Tsuji W; Shintaku M; Yotsumoto F
    BMC Cancer; 2018 Dec; 18(1):1282. PubMed ID: 30577860
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. A historical cohort study on glycemic-control and cancer-risk among patients with diabetes.
    Dankner R; Boker LK; Boffetta P; Balicer RD; Murad H; Berlin A; Olmer L; Agai N; Freedman LS
    Cancer Epidemiol; 2018 Dec; 57():104-109. PubMed ID: 30388485
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Recurrence Patterns After Anatomic or Parenchyma-Sparing liver Resection for Hepatocarcinoma in a Western Population of Cirrhotic Patients.
    Famularo S; Di Sandro S; Giani A; Lauterio A; Sandini M; De Carlis R; Buscemi V; Uggeri F; Romano F; Gianotti L; De Carlis L
    Ann Surg Oncol; 2018 Dec; 25(13):3974-3981. PubMed ID: 30244421
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 5.